1446
I. Izquierdo et al. / Tetrahedron 63 (2007) 1440–1447
and 3273 (OH, NH), 3064 (aromatic), 1724 (CO, Bz), 739
and 704 cmꢀ1 (aromatic). 1H NMR (300 MHz): d 8.10–7.23
HRMS (LSIMS): m/z 856.2918 [M++Na]; calcd for
C51H51NO8NaSi: 856.2917 (deviation ꢀ0.1 ppm).
0
0
0
(3m, 20H, 4Ph), 4.65 (dd, 1H, J2,2 a 6.6, J2 a,2 b 11.1 Hz,
H-20a), 4.59 and 4.52 (2d, 2H, J 11.9 Hz, CH2Ph), 4.46
(dd, 1H, J2,2 b 6.5 Hz, H-20b), 4.13 (d, 1H, J2,3 3.3 Hz,
4.1.14. N-Benzylation of 18. To a stirred solution of 18
(780 mg, 1.3 mmol) in dry acetonitrile (10 mL), DBU
(0.8 mL, 5.2 mmol) and benzyl bromide (0.5 mL,
3.9 mmol) were added and the mixture was left at room tem-
perature for 4 days. TLC (2:1, ether/hexane) then showed the
presence of two less polar compounds. The reaction mixture
was concentrated and the residue was subjected to column
chromatography (1:2/1:1 ether/hexane) to yield first
(2S,3R,4R,5R)-20-O-benzoyl-N-benzyl-4-benzyloxy-50-O-
tert-butyldiphenylsilyl-3-hydroxy-2,5-bis(hydroxymethyl)-
pyrrolidine (22, 460 mg, 52%) as a colourless syrup; [a]D23
+27 (c 1); n (neat) 3444 (OH), 3068 and 3025 (aromatic),
1719 (CO, Bz) and 704 cmꢀ1 (aromatic). 1H NMR
(400 MHz): d 8.06–8.03, 7.66–7.55 and 7.46–7.20 (3m,
0
0
H-3), 3.88 (d, 1H, J4,5 2.3 Hz, H-4), 3.73 (dd, 1H, J5,5 a
3.9, J5 a,5 b 10.5 Hz, H-50a), 3.68 (dd, 1H, J5,5 b 3.6 Hz,
H-50b), 3.62 (dt, 1H, H-2), 3.34 (q, 1H, H-5), and 1.05 (s,
9H, CMe3). 13C NMR (inter alia): d 166.80 (COPh), 87.36
and 74.81 (C-3,4), 71.82 (CH2Ph), 65.56 and 64.09
(C-20,50), 65.01 and 60.69 (C-2,5), 26.92 (CMe3) and 19.24
(CMe3). HRMS (LSIMS): m/z 618.2653 [M++Na]; calcd
for C36H41NO5NaSi: 618.2652 (deviation ꢀ0.1 ppm).
0
0
0
Second elution gave syrupy (2R,3R,4R,5S)-4-benzoyloxy-
3-benzyloxy-20-O-tert-butyldiphenylsilyl-2,5-bis(hydroxy-
26
405
methyl)pyrrolidine (18, 2.57 g, 43%); [a]2D5 ꢀ9; [a] ꢀ35
25H, 5Ph), 4.65 (dd, 1H, J2,2 a 8.0, J2 a,2 b 11.0 Hz, H-20a),
0
0
0
(c 1.6); n (neat) 3593 and 3500 (OH, NH), 3063 (aromatic),
1
1721 (CO, Bz), 709 and 700 cmꢀ1 (aromatic). H NMR
4.57 (dd, 1H, J2,2 b 6.0 Hz, H-20b), 4.60 and 4.54 (2d, 2H, J
0
(300 MHz): d 8.10–7.25 (3m, 20H, 4Ph), 5.54 (dd, 1H, J3,4
1.8, J4,5 4.2 Hz, H-4), 4.78 and 4.60 (2d, 2H, J 11.8 Hz,
CH2Ph), 4.12 (dd, 1H, J2,3 4.8 Hz, H-3), 3.88 (dd, 1H,
12.0 Hz, OCH2Ph), 4.21 (dd, 1H, J3,4 10.3, J2,3 3.6 Hz,
H-3), 4.08 and 3.80 (2d, 2H, J 14.1 Hz, NCH2Ph), 3.98 (br
s, 1H, OH), 3.96 (d, 1H, H-4), 3.62 (m, 1H, H-2), 3.43 (dd,
J2,2 a 5.2, J2 a,2 b 10.4 Hz, H-20a), 3.80 (dd, 1H, J2,2 b
4.8 Hz, H-20b), 3.77–3.67 (m, 3H, H-5,50a,50b), 3.37 (q,
1H, H-2), 2.90 (br s, 2H, NH, OH) and 1.05 (s, 9H,
CMe3). 13C NMR (inter alia): d 166.0 (COPh), 85.07 and
79.27 (C-3,4), 72.22 (CH2Ph), 64.82 and 61.61 (C-2,5),
64.22 and 60.82 (C-20,50), 26.82 (CMe3) and 19.21
(CMe3). HRMS (LSIMS): m/z 618.2652 [M++Na]; calcd
for C36H41NO5NaSi: 618.2652 (deviation 0.0 ppm).
1H, J5,5 a 2.7, J5 a,5 b 10.5 Hz, H-50a), 3.36 (dd, 1H, J5,5 b
3.8 Hz, H-50b), 3.09 (br t, 1H, H-5) and 1.06 (s, 9H, CMe3).
13C NMR (inter alia): d 166.68 (COPh), 85.69 (C-4), 74.10
(C-3), 71.69 (C-5), 71.25 (OCH2Ph), 66.10 (C-2), 65.03
(C-50), 63.30 (C-20), 58.26 (NCH2Ph), 26.88 (CMe3) and
19.16 (CMe3). HRMS (LSIMS): m/z 708.3122 [M++Na];
calcd for C43H47NO5NaSi: 708.3121 (deviation ꢀ0.2 ppm).
0
0
0
0
0
0
0
0
Second elution gave (2R,3R,4R,5S)-4-benzoyloxy-N-benzyl-
3-benzyloxy-20-O-tert-butyldiphenylsilyl-4-hydroxy-2,5-
bis(hydroxymethyl)pyrrolidine (23, 87 mg, 10%) as a
colourless syrup; [a]D24 ꢀ30 (c 1); n (neat) 3460 (OH),
3067 and 3028 (aromatic), 1719 (CO, Bz), 736 and
4.1.13. N-Benzyloxycarbonylation of 18. To a cooled
(0 ꢁC) and stirred solution of 18 (1.87 g, 3.1 mmol) in anhy-
drous MeOH (20 mL) and TEA (1.4 mL, 10.8 mmol) was
added benzyl chloroformate (560 mL, 3.9 mmol) and the
mixture was allowed to reach room temperature. TLC (3:1
ether/hexane) then showed the presence of a faster-running
compound. The solvent was eliminated and the residue was
partitioned in DCM/water, the organic phase was concen-
trated to yield an unresolvable mixture of 19 and 20 (1.9 g,
84%) (1H NMR evidence) that was used in the next step.
1
708 cmꢀ1 (aromatic). H NMR (400 MHz): d 8.04–8.01,
7.63–7.58 and 7.46–7.20 (3m, 25H, 5Ph), 5.57 (dd, 1H,
J3,4 4.3, J4,5 6.3 Hz, H-4), 4.74 and 4.66 (2d, 2H, J
11.7 Hz, OCH2Ph), 4.43 (t, 1H, J2,3 4.3 Hz, H-3), 3.92 and
0
3.88 (2d, 2H, J 13.6 Hz, NCH2Ph), 3.73 (dd, 1H, J2,2 a 6.4,
0
J2 a,2 b 10.6 Hz, H-20a), 3.60 (dd, 1H, J2,2 b 4.1 Hz, H-20b),
0
0
3.55 (dt, 1H, J5,5 a 2.1 Hz, H-5), 3.50 (dd, 1H, H-50a),
0
3.34 (dd, 1H, J5,5 b 5.8, J5a,5 b 11.4 Hz, H-50b), 3.21 (dt,
1H, H-2) and 1.06 (s, 9H, CMe3). 13C NMR (inter alia):
d 166.51 (COPh), 82.05 (C-3), 78.30 (C-4), 72.12
(OCH2Ph), 69.02 and 65.13 (C-2,5), 63.33 and 59.20 (C-
20,50), 58.52 (NCH2Ph), 26.89 (CMe3) and 19.21 (CMe3).
HRMS (LSIMS): m/z 708.3121 [M++Na]; calcd for
C43H47NO5-NaSi: 708.3121 (deviation 0.0 ppm).
0
0
When compound 17 was treated as above the same mixture
was obtained.
To a stirred solution of the above mixture (19 and 20, 3.31 g,
4.5 mmol) and TEA (2.5 mL, 18 mmol) in anhydrous DCM
(30 mL) was added dropwise benzoyl chloride (1.6 mL,
13.6 mmol) and the mixture was left at room temperature
for 12 h. TLC (2:1 ether/hexane) then showed a faster-
running compound. Conventional work-up and column
chromatography afforded (2S,3R,4R,5R)-20-O-benzoyl-3-
benzoyloxy-4-benzyloxy-N-benzyloxycarbonyl-50-O-tert-
butyldiphenylsilyl-2,5-bis(hydroxymethyl)pyrrolidine (21,
3.5 g, 93%) as a colourless syrup; [a]2D4 +11 (c 1); n (neat)
3065 and 3028 (aromatic), 1731 (CO, Bz), 1704 (CO,
4.1.15. N-Allylation of 18. To a solution of 18 (2.53 g,
4.25 mmol) in dry acetone (30 mL), anhydrous K2CO3
(2.9 g) and allyl bromide (1.3 mL, 15 mmol) were added and
the mixture sonicated for 30 min and then stirred at room
temperature for 24 h. TLC (ether) then showed the presence
of two less polar compounds. The reaction mixture was fil-
tered and the solid was washed with acetone. Removal of
the solvent gave a residue that was partitioned into DCM/
water, the organic phase was separated and concentrated.
Column chromatography (1:3 ether/hexane) of the residue
yielded first (2S,3R,4R,5R)-N-allyl-20-O-benzoyl-4-benzyl-
oxy-50-O-tert-butyldiphenylsilyl-3-hydroxy-2,5-bis(hydroxy-
methyl)pyrrolidine (24, 1.84 g, 68%) as a colourless syrup;
1
Cbz), 745 and 711 cmꢀ1 (aromatic). H NMR (300 MHz):
d 7.86–7.12 (3m, 30H, 6Ph), 5.78 (br s, 1H, H-3), 5.08
(br s, 2H, H-20a,20b), 4.80–3.72 (4m, 9H, 2CH2Ph,
H-2,4,5,50a,50b) and 1.05 (s, 9H, CMe3). 13C NMR
(inter alia): d 165.85 and 165.42 (2COPh), 155.53 (CO,
Cbz), 72.08 (2CH2Ph), 67.47 (C-20,50), 64.63, 64.57, 62.40
and 62.17 (C-2,3,4,5), 26.89 (CMe3) and 19.25 (CMe3).